Chronic kidney disease (CKD) is defined as a progressive loss of renal function that lasts for more than 3 months, and is classified according to the degree of kidney damage – measured by the le ...
Isuzinaxib is under clinical development by AptaBio Therapeutics and currently in Phase II for Acute Renal Failure (ARF) (Acute Kidney Injury). According to GlobalData ... It was also under ...
Deka Biosciences is a pharmaceutical company which is developing next generation targeted cytokine therapies to treat cancer and inflammatory diseases. The company is headquartered in Germantown, ...
Far from a simple slice of turkey and dollop of cranberry on wholemeal bread, well-crafted Christmas sandwiches have the power to transform lunchtimes for the entire duration of November and December.
If chronic kidney disease (CKD) is left untreated, it can lead to complications like anemia and high blood pressure, which can worsen kidney function and contribute to other health issues.
Some research supports statin use for people with kidney disease or kidney failure and heart disease. Other research recommends caution for those with kidney issues. Heart disease is a major cause ...